Anika Therapeutics (ANIK) Return on Invested Capital: 2011-2024
Historic Return on Invested Capital for Anika Therapeutics (ANIK) over the last 11 years, with Sep 2024 value amounting to 0.05%.
- Anika Therapeutics' Return on Invested Capital was N/A to 0.05% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.05%, marking a year-over-year change of. This contributed to the annual value of 0.00% for FY2022, which is N/A change from last year.
- Latest data reveals that Anika Therapeutics reported Return on Invested Capital of 0.05% as of Q3 2024, which was up 119.73% from 0.02% recorded in Q2 2024.
- Over the past 5 years, Anika Therapeutics' Return on Invested Capital peaked at 0.10% during Q1 2020, and registered a low of -0.09% during Q1 2021.
- Over the past 2 years, Anika Therapeutics' median Return on Invested Capital value was 0.01% (recorded in 2022), while the average stood at -0.00%.
- Per our database at Business Quant, Anika Therapeutics' Return on Invested Capital dropped by 19bps in 2021 and then rose by 1bps in 2022.
- Quarterly analysis of 4 years shows Anika Therapeutics' Return on Invested Capital stood at -0.08% in 2020, then declined by 1bps to -0.02% in 2021, then declined by 3bps to 0.00% in 2022, then reached 0.05% in 2024.
- Its Return on Invested Capital stands at 0.05% for Q3 2024, versus 0.02% for Q2 2024 and 0.02% for Q1 2024.